Idiopathic Pulmonary Fibrosis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

With Pulmonary Fibrosis, Stress Can Cause Physiological Responses - Pulmonary Fibrosis News



Pulmonary Fibrosis News
 
With Pulmonary Fibrosis, Stress Can Cause Physiological Responses 
Pulmonary Fibrosis News
Did you know that excessive stress can have physiological effects, such as pain? Columnist Charlene Marshall writes about what she learned at a recent rheumatology appointment.
Veracyte (VCYT) Reports Publication of Results from Patient Survey on Challenges in Diagnosing Interstitial Lung ... StreetInsider.com

all 2 news articles » 


IPF Therapy Ofev Is Subject of Canadian Safety Warning After Liver ... - Pulmonary Fibrosis News



Lung Disease News
 
IPF Therapy Ofev Is Subject of Canadian Safety Warning After Liver ... 
Pulmonary Fibrosis News
Read about Canadian health officials issuing a safety warning on the pulmonary fibrosis therapy Ofev after cases of liver injury.
Pulmonary Fibrosis Therapy Ofev Is Subject of Health Canada ... Lung Disease News

all 2 news articles » 


Improving Prognosis in Idiopathic Pulmonary Fibrosis-Associated Pulmonary Hypertension - Pulmonology Advisor



Pulmonology Advisor
 
Improving Prognosis in Idiopathic Pulmonary Fibrosis-Associated Pulmonary Hypertension 
Pulmonology Advisor
Patients with IPF-associated pulmonary hypertension treated with bosentan experienced improvements in hospital-free survival. An interim report of a long-term ongoing prospective single-center study evaluating the effects of bosentan on idiopathic ...
Reflecting on a Year Passed Pulmonary Fibrosis News

all 3 news articles » 


Pulmonary fibrosis caused by single transcription factor - Science Daily



Pulmonary fibrosis caused by single transcription factor 
Science Daily
An important role in idiopathic pulmonary fibrosis is played by connective tissue cells called fibroblasts. These cells provide structure to the air sacs (alveoli) in the lungs. During development of the disease, characteristic changes to these ...

and more » 


3 Tips for Setting Intentional New Year's Resolutions - Pulmonary Fibrosis News



Pulmonary Fibrosis News
 
3 Tips for Setting Intentional New Year's Resolutions 
Pulmonary Fibrosis News
For patients living with idiopathic pulmonary fibrosis (IPF) or any chronic lung disease, it's known that an acute exacerbation, illness or fluke decrease in lung function could drastically change their ability to breathe. Since this can and does ...

and more » 


World's Leading Lung Disease Experts Join NuMedii's Idiopathic Pulmonary Fibrosis Advisory Board - Markets Insider



World's Leading Lung Disease Experts Join NuMedii's Idiopathic Pulmonary Fibrosis Advisory Board 
Markets Insider
MENLO PARK, Calif., Jan. 8, 2018 /PRNewswire/ -- NuMedii, Inc. today announced the formation of an Idiopathic Pulmonary Fibrosis (IPF) Advisory Board consisting of the world's leading experts in interstitial lung disease: Naftali Kaminski, MD; David A ...

and more » 


FoxO3 Protein Found to Be Key Regulator of Fibrosis in Lungs, Study Finds - Lung Disease News



Lung Disease News
 
FoxO3 Protein Found to Be Key Regulator of Fibrosis in Lungs, Study Finds 
Lung Disease News
Next, they tested mice genetically manipulated to not have FoxO3, and found that these animals developed pulmonary fibrosis faster than mice with the protein. ?These mice developed idiopathic pulmonary fibrosis much more quickly than control animals ...

 


Phase 2 Study in IPF Patients of Tralokinumab, Anti-IL-13 Antibody, Stopped for Lack of Efficacy - Pulmonary Fibrosis News



Phase 2 Study in IPF Patients of Tralokinumab, Anti-IL-13 Antibody, Stopped for Lack of Efficacy 
Pulmonary Fibrosis News
Interim results of a Phase 2 clinical trial found an investigative antibody, tralokinumab, failed to demonstrate potential to improve the respiratory function of patients with idiopathic pulmonary fibrosis (IPF). Based on this final, the study has been ...

 


ASLAN Pharmaceuticals Appoints Stephen Doyle as Head of China - Markets Insider



ASLAN Pharmaceuticals Appoints Stephen Doyle as Head of China 
Markets Insider
At Boehringer Ingelheim, he led the marketing and sales for oncology, biosimilars and rare diseases in China, launching Giotrif® for non-small cell lung cancer and securing the approval for Ofev® for idiopathic pulmonary fibrosis. In his new role, Mr ...

and more » 


Trust carries out vital research of IPF which claimed Keith Chegwin's ... - Malvern Gazette



Malvern Gazette
 
Trust carries out vital research of IPF which claimed Keith Chegwin's ... 
Malvern Gazette
SPECIALIST staff at Worcestershire Acute Hospitals NHS Trust are at the forefront of raising awareness and of work to help sufferers of a?

and more »